Development of Targeted Anticytomegalovirus Therapies

Reist, Elmer J.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 1U01AI033375-01
• Application #: 3548066
• Study Section: Special Emphasis Panel (SRC (77))
• Project Start: 1992-09-01
• Project End: 1995-08-31
• Budget Start: 1992-09-01
• Budget End: 1993-08-31
• Support Year: 1
• Fiscal Year: 1992

Institution

• Name: Sri International
• City: Menlo Park
• State: CA
• Country: United States
• Zip Code: 94025

Publications

Smee, D F; Reist, E J (1996) Potent anti-murine cytomegalovirus activity and reduced nephrotoxicity of ganciclovir cyclic phosphonate. Antimicrob Agents Chemother 40:1964-6

Smee, D F; Barnett, B B; Sidwell, R W et al. (1995) Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus. Antiviral Res 26:1-9

Smee, D F; Sugiyama, S T; Reist, E J (1994) Nucleotide analogs related to acyclovir and ganciclovir are effective against murine cytomegalovirus infections in BALB/c and severe combined immunodeficient mice. Antimicrob Agents Chemother 38:2165-8